CEPI fast-tracks ebola vaccine candidates from IAVI, Moderna and Oxford

The Coalition for Epidemic Preparedness Innovations (CEPI) announced the fast-tracking of three investigational vaccines to combat the Bundibugyo ebolavirus (BDBV) epidemic in the Democratic Republic of the Congo (DRC) and Uganda. CEPI selected IAVI, Moderna and the University of Oxford’s vaccine candidates based on a global review and consultations with the WHO, Africa CDC and… The post CEPI fast-tracks ebola vaccine candidates from IAVI, Moderna and Oxford appeared first on Drug Discovery and Development.

Continue reading →